Lurbinectedin
ZEPZELCA
Alkylating Drug
NADAC/unit
N/A
No Shortage
Lurbinectedin damages cancer cell DNA to prevent tumor growth.
Generic Manufacturers
JAZZ PHARMACEUTICALS IRELAND LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
